combination drug fixed-dose combination fdc medicine includes two active ingredient combined single dosage form
term like combination drug combination drug product common shorthand fdc product since combination drug product currently fdcs although latter precise fact referring mass-produced product predetermined combination drug respective dosage opposed customized polypharmacy via compounding
also distinguished term combination product medical context without specification refer product combine different type medical productssuch devicedrug combination opposed drugdrug combinations
note combination drug product whether fixed-dose pill ie tablet capsule also kind polypill combopill
initially fixed-dose combination drug product developed target single disease antiretroviral fdcs used aids
case fdcs targeting multiple condition condition might often relatedin order increase number prospective patient might likely utilize given fdc product
fdc product mass-produced thus typically requires critical mass potentially applicable patient order justify manufacture distribution stocking etc
glucosefructosephosphoric acid antiemetic taken relieve nausea vomitingprescription drugs
adderall dextroamphetamine sulfateamphetamine sulfatedextroamphetamine saccharateamphetamine aspartate monohydrate treatment attention deficit hyperactivity disorder adhd narcolepsy
nirmatrelvirritonavir granted emergency use authorization eua u food drug administration fda treatment management covid-in addition simply mean facilitating general advantage combination therapy specific advantage fixed-dose combination fdc drug product include
note pill burden number pill needing taken also associated burden keeping track several medication understanding various instruction etc
ability compose combined profile example pharmacokinetics effect adverse effect may specific relative dosage given fdc product providing simpler overview compared looking profile single drug individually
combined profile also include effect caused interaction individual drug may omitted individual drug profiles
since fdcs reviewed regulating agency food drug administration united state active ingredient used fdcs unlikely exhibit adverse drug interaction other
however fdcs may interact drug patient taking usual medical pharmaceutical precaution drug-drug interaction ddi remain warranted
fdc drug product may developed pharmaceutical company way effect extend proprietary right marketability drug product
since fdcs may protected patent company may obtain exclusive right sell particular fdc formulation thereof even though individual active ingredient many therapeutic us thereof may off-patentthere may fdc available appropriate drug andor appropriate respective strength given patient lead patient getting
pharmaceutical compounding practice preparing individualized drug product individual patient aid polypharmacy
adverse drug reaction occurs using fdc may difficult identify active ingredient responsible causing reaction
problem might alleviated starting medication individually monitoring reaction switching fdc problem observed assuming course active ingredient causing problem
formulation scientist experience challenge development stage multi-drug formulation compatibility issue among active ingredient excipients affecting solubility dissolution
one drug contraindicated patient whole fdc cannot prescribed